OKUR – onkure therapeutics, inc. - class a (US:NASDAQ)
Stock Stats
News
OnKure Therapeutics (NASDAQ:OKUR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
OnKure Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Business Update
OnKure Therapeutics to Participate in Upcoming Investor Conferences
OnKure Therapeutics (NASDAQ:OKUR) was upgraded by analysts at Wall Stree
Form 4 OnKure Therapeutics, For: Dec 31 Filed by: Mathers Edward T
Form 4 OnKure Therapeutics, For: Dec 31 Filed by: Manke Isaac
Form 4 OnKure Therapeutics, For: Dec 22 Filed by: Saccomano Nicholas A
Form 4 OnKure Therapeutics, For: Dec 22 Filed by: Leverone Jason A.
Form SCHEDULE 13G OnKure Therapeutics, Filed by: Prosight Management, LP
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.